

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.59928097 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.59928097 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.98990388 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.98990388 |
| 5 | neutrophil mediated immunity (GO:0002446) | 4.92224605 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.91179750 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.91179750 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 4.86666341 |
| 9 | leukocyte aggregation (GO:0070486) | 4.83191750 |
| 10 | cellular response to zinc ion (GO:0071294) | 4.78911378 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.72843958 |
| 12 | regulation of cholesterol esterification (GO:0010872) | 4.65782397 |
| 13 | negative regulation of phagocytosis (GO:0050765) | 4.58902106 |
| 14 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.49410545 |
| 15 | response to fungus (GO:0009620) | 4.23779303 |
| 16 | defense response to fungus (GO:0050832) | 4.15956620 |
| 17 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06856786 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.06518018 |
| 19 | regulation of protein activation cascade (GO:2000257) | 4.03096878 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00405357 |
| 21 | plasma lipoprotein particle assembly (GO:0034377) | 3.98076518 |
| 22 | regulation of complement activation (GO:0030449) | 3.97473890 |
| 23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.93048603 |
| 24 | myeloid leukocyte mediated immunity (GO:0002444) | 3.91007762 |
| 25 | plasma lipoprotein particle remodeling (GO:0034369) | 3.90657880 |
| 26 | protein-lipid complex remodeling (GO:0034368) | 3.90657880 |
| 27 | macromolecular complex remodeling (GO:0034367) | 3.90657880 |
| 28 | cholesterol efflux (GO:0033344) | 3.88583156 |
| 29 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.82113861 |
| 30 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.82113861 |
| 31 | respiratory burst (GO:0045730) | 3.81717413 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.76595051 |
| 33 | negative regulation of growth of symbiont in host (GO:0044130) | 3.74657630 |
| 34 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.74657630 |
| 35 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.74657630 |
| 36 | regulation of growth of symbiont in host (GO:0044126) | 3.74657630 |
| 37 | regulation of fibrinolysis (GO:0051917) | 3.68201350 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.64569487 |
| 39 | detection of other organism (GO:0098543) | 3.61998524 |
| 40 | complement activation, alternative pathway (GO:0006957) | 3.60883636 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.55495688 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.53545180 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.53265394 |
| 44 | protein-lipid complex assembly (GO:0065005) | 3.52418347 |
| 45 | blood coagulation, intrinsic pathway (GO:0007597) | 3.46253003 |
| 46 | negative regulation of fibrinolysis (GO:0051918) | 3.44905932 |
| 47 | L-ascorbic acid metabolic process (GO:0019852) | 3.44391924 |
| 48 | phospholipid efflux (GO:0033700) | 3.43772534 |
| 49 | ethanol oxidation (GO:0006069) | 3.43134090 |
| 50 | interferon-gamma production (GO:0032609) | 3.43127282 |
| 51 | detection of bacterium (GO:0016045) | 3.43079561 |
| 52 | mast cell activation (GO:0045576) | 3.42574369 |
| 53 | plasma lipoprotein particle organization (GO:0071827) | 3.41326978 |
| 54 | disruption of cells of other organism (GO:0044364) | 3.40904218 |
| 55 | killing of cells of other organism (GO:0031640) | 3.40904218 |
| 56 | cellular extravasation (GO:0045123) | 3.38363012 |
| 57 | reverse cholesterol transport (GO:0043691) | 3.35911177 |
| 58 | xenobiotic catabolic process (GO:0042178) | 3.32235311 |
| 59 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31958002 |
| 60 | NADH metabolic process (GO:0006734) | 3.30971348 |
| 61 | aromatic amino acid family catabolic process (GO:0009074) | 3.30734874 |
| 62 | oxidative phosphorylation (GO:0006119) | 3.30417912 |
| 63 | T cell migration (GO:0072678) | 3.28632586 |
| 64 | epoxygenase P450 pathway (GO:0019373) | 3.28541842 |
| 65 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.25635338 |
| 66 | protein carboxylation (GO:0018214) | 3.25635338 |
| 67 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.25576138 |
| 68 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.23685273 |
| 69 | ATP synthesis coupled proton transport (GO:0015986) | 3.23685273 |
| 70 | neutrophil activation (GO:0042119) | 3.23571352 |
| 71 | respiratory electron transport chain (GO:0022904) | 3.23335495 |
| 72 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.22146750 |
| 73 | protein-lipid complex subunit organization (GO:0071825) | 3.19861887 |
| 74 | intestinal absorption (GO:0050892) | 3.19654245 |
| 75 | intestinal cholesterol absorption (GO:0030299) | 3.17303261 |
| 76 | electron transport chain (GO:0022900) | 3.16318446 |
| 77 | negative regulation of protein activation cascade (GO:2000258) | 3.14244270 |
| 78 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.13049882 |
| 79 | leukocyte mediated cytotoxicity (GO:0001909) | 3.11541847 |
| 80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.09701516 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.09701516 |
| 82 | polyketide metabolic process (GO:0030638) | 3.07734477 |
| 83 | doxorubicin metabolic process (GO:0044598) | 3.07734477 |
| 84 | daunorubicin metabolic process (GO:0044597) | 3.07734477 |
| 85 | transcytosis (GO:0045056) | 3.06882734 |
| 86 | dendritic cell chemotaxis (GO:0002407) | 3.06465225 |
| 87 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.05170034 |
| 88 | angiotensin maturation (GO:0002003) | 3.05081612 |
| 89 | plasma lipoprotein particle clearance (GO:0034381) | 3.04336928 |
| 90 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.03563819 |
| 91 | DNA deamination (GO:0045006) | 3.03401341 |
| 92 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.02633333 |
| 93 | megakaryocyte development (GO:0035855) | 3.02475400 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.00205201 |
| 95 | hepatocyte apoptotic process (GO:0097284) | 2.99292116 |
| 96 | negative T cell selection (GO:0043383) | 2.98129441 |
| 97 | reactive oxygen species biosynthetic process (GO:1903409) | 2.96402927 |
| 98 | ethanol metabolic process (GO:0006067) | 2.94483860 |
| 99 | regulation of B cell differentiation (GO:0045577) | 2.94269246 |
| 100 | regulation of respiratory burst (GO:0060263) | 2.92164366 |
| 101 | superoxide anion generation (GO:0042554) | 2.90819929 |
| 102 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90487339 |
| 103 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.90173868 |
| 104 | granulocyte activation (GO:0036230) | 2.89411411 |
| 105 | uronic acid metabolic process (GO:0006063) | 2.89403830 |
| 106 | glucuronate metabolic process (GO:0019585) | 2.89403830 |
| 107 | negative regulation of sterol transport (GO:0032372) | 2.89024823 |
| 108 | negative regulation of cholesterol transport (GO:0032375) | 2.89024823 |
| 109 | acute-phase response (GO:0006953) | 2.86831226 |
| 110 | respiratory chain complex IV assembly (GO:0008535) | 2.85349122 |
| 111 | dendritic cell migration (GO:0036336) | 2.84253201 |
| 112 | negative regulation of complement activation (GO:0045916) | 2.83250057 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83085298 |
| 114 | response to peptidoglycan (GO:0032494) | 2.82765617 |
| 115 | negative thymic T cell selection (GO:0045060) | 2.81952680 |
| 116 | leukocyte degranulation (GO:0043299) | 2.81704695 |
| 117 | cytochrome complex assembly (GO:0017004) | 2.80954661 |
| 118 | lipoprotein metabolic process (GO:0042157) | 2.80426448 |
| 119 | mast cell activation involved in immune response (GO:0002279) | 2.80408864 |
| 120 | mast cell degranulation (GO:0043303) | 2.80408864 |
| 121 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79988363 |
| 122 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79690970 |
| 123 | cellular glucuronidation (GO:0052695) | 2.78513240 |
| 124 | bile acid metabolic process (GO:0008206) | 2.77618725 |
| 125 | urate metabolic process (GO:0046415) | 2.76704484 |
| 126 | regulation of oxidative phosphorylation (GO:0002082) | 2.76389996 |
| 127 | protein complex biogenesis (GO:0070271) | 2.74778004 |
| 128 | protein activation cascade (GO:0072376) | 2.74352588 |
| 129 | cellular response to interferon-beta (GO:0035458) | 2.74305446 |
| 130 | fibrinolysis (GO:0042730) | 2.74193960 |
| 131 | negative regulation of blood coagulation (GO:0030195) | 2.73807111 |
| 132 | negative regulation of hemostasis (GO:1900047) | 2.73807111 |
| 133 | response to type I interferon (GO:0034340) | 2.73431170 |
| 134 | lymphoid progenitor cell differentiation (GO:0002320) | 2.72995169 |
| 135 | oxaloacetate metabolic process (GO:0006107) | 2.72750833 |
| 136 | cholesterol homeostasis (GO:0042632) | 2.72698850 |
| 137 | angiogenesis involved in wound healing (GO:0060055) | 2.71542113 |
| 138 | negative regulation of coagulation (GO:0050819) | 2.71089436 |
| 139 | complement activation, classical pathway (GO:0006958) | 2.71074798 |
| 140 | fatty acid beta-oxidation (GO:0006635) | 2.70957159 |
| 141 | triglyceride homeostasis (GO:0070328) | 2.70825705 |
| 142 | acylglycerol homeostasis (GO:0055090) | 2.70825705 |
| 143 | positive regulation of granulocyte differentiation (GO:0030854) | 2.70790256 |
| 144 | viral transcription (GO:0019083) | 2.69269174 |
| 145 | regulation of chemokine biosynthetic process (GO:0045073) | 2.69226501 |
| 146 | cellular response to type I interferon (GO:0071357) | 2.68533154 |
| 147 | type I interferon signaling pathway (GO:0060337) | 2.68533154 |
| 148 | vitamin biosynthetic process (GO:0009110) | 2.67520246 |
| 149 | sterol homeostasis (GO:0055092) | 2.67419459 |
| 150 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.67094352 |
| 151 | necroptotic process (GO:0070266) | 2.66888310 |
| 152 | negative regulation of granulocyte differentiation (GO:0030853) | 2.66759860 |
| 153 | aerobic respiration (GO:0009060) | 2.66682611 |
| 154 | glycoside metabolic process (GO:0016137) | 2.66589855 |
| 155 | definitive hemopoiesis (GO:0060216) | 2.66240967 |
| 156 | * leukotriene metabolic process (GO:0006691) | 2.65687314 |
| 157 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.65503172 |
| 158 | sterol transport (GO:0015918) | 2.65168834 |
| 159 | cholesterol transport (GO:0030301) | 2.65168834 |
| 160 | fatty acid catabolic process (GO:0009062) | 2.63433057 |
| 161 | bile acid biosynthetic process (GO:0006699) | 2.63230946 |
| 162 | oligosaccharide catabolic process (GO:0009313) | 2.62562461 |
| 163 | leukocyte cell-cell adhesion (GO:0007159) | 2.62434973 |
| 164 | defense response to protozoan (GO:0042832) | 2.62357560 |
| 165 | cellular response to interleukin-15 (GO:0071350) | 2.61837487 |
| 166 | fructose metabolic process (GO:0006000) | 2.61805085 |
| 167 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.61107580 |
| 168 | response to protozoan (GO:0001562) | 2.60742490 |
| 169 | myeloid dendritic cell activation (GO:0001773) | 2.60668332 |
| 170 | T cell homeostasis (GO:0043029) | 2.58739987 |
| 171 | primary alcohol catabolic process (GO:0034310) | 2.58006351 |
| 172 | short-chain fatty acid metabolic process (GO:0046459) | 2.57957069 |
| 173 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.56915973 |
| 174 | glyoxylate metabolic process (GO:0046487) | 2.56229457 |
| 175 | diacylglycerol metabolic process (GO:0046339) | 2.55617546 |
| 176 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.55029772 |
| 177 | aldehyde catabolic process (GO:0046185) | 2.55026717 |
| 178 | regulation of metalloenzyme activity (GO:0048552) | 2.54173400 |
| 179 | translational termination (GO:0006415) | 2.54070370 |
| 180 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.53240808 |
| 181 | detection of external biotic stimulus (GO:0098581) | 2.50827550 |
| 182 | response to interleukin-15 (GO:0070672) | 2.49150085 |
| 183 | actin nucleation (GO:0045010) | 2.48942549 |
| 184 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.47623888 |
| 185 | myeloid cell activation involved in immune response (GO:0002275) | 2.47050723 |
| 186 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.46994977 |
| 187 | mature B cell differentiation involved in immune response (GO:0002313) | 2.45671767 |
| 188 | regulation of response to interferon-gamma (GO:0060330) | 2.45598644 |
| 189 | glucose 6-phosphate metabolic process (GO:0051156) | 2.45294507 |
| 190 | ribosomal small subunit biogenesis (GO:0042274) | 2.45154792 |
| 191 | signal peptide processing (GO:0006465) | 2.44868151 |
| 192 | cotranslational protein targeting to membrane (GO:0006613) | 2.44633874 |
| 193 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.44592929 |
| 194 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.44501634 |
| 195 | B cell receptor signaling pathway (GO:0050853) | 2.44359111 |
| 196 | protein targeting to ER (GO:0045047) | 2.43758582 |
| 197 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.43668250 |
| 198 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.41744779 |
| 199 | L-fucose catabolic process (GO:0042355) | 2.40635904 |
| 200 | L-fucose metabolic process (GO:0042354) | 2.40635904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.30511496 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.79558161 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.69032751 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.00990001 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.90773558 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.68255988 |
| 7 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63181860 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.61949600 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.52114746 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.45712623 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44567366 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.43180202 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41675003 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.33145638 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.18549466 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.11841002 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.08062577 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82094685 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79227530 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.78521216 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.74724259 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.74219280 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70150785 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68370621 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67772785 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.50502858 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.50209172 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.48738379 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.37892432 |
| 30 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37463945 |
| 31 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34380857 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.33570619 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33556656 |
| 34 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30186163 |
| 35 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.20187377 |
| 36 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.17878625 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 2.17864076 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.15824727 |
| 39 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15260790 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.12197688 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05177482 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00869818 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92819252 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.90856587 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85614132 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.84108931 |
| 47 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.83103010 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83100975 |
| 49 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81371446 |
| 50 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.79685554 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78578393 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75303163 |
| 53 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72866746 |
| 54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.72348283 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71085191 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68762574 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.66073491 |
| 58 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.63130482 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62765434 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62367892 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57527181 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.55849495 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54820278 |
| 64 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.53337793 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51431611 |
| 66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.48065055 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42003451 |
| 68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41733072 |
| 69 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.41594715 |
| 70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40594968 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.38924455 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38899511 |
| 73 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37678729 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36045245 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.34846652 |
| 76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33020234 |
| 77 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.29813561 |
| 78 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28285397 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.27615061 |
| 80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27464574 |
| 81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25110740 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24485508 |
| 83 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.23928341 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23514065 |
| 85 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.23170973 |
| 86 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22752914 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21622805 |
| 88 | AR_20517297_ChIP-Seq_VCAP_Human | 1.21507165 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21304349 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20877976 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.20479279 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.19130614 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18483142 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18059649 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17504480 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16130300 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15917875 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15221571 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14796545 |
| 100 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14684012 |
| 101 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13519711 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12670407 |
| 103 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12208221 |
| 104 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.11942346 |
| 105 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.11237168 |
| 106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.11072510 |
| 107 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11038519 |
| 108 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.10612369 |
| 109 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.10104090 |
| 110 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09146066 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08884060 |
| 112 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08840521 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.07849425 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07410486 |
| 115 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07407494 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07309997 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05844525 |
| 118 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.03521926 |
| 119 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03517744 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02336259 |
| 121 | MAF_26560356_Chip-Seq_TH2_Human | 1.01280727 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00775514 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99652865 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99259951 |
| 125 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97551580 |
| 126 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96849730 |
| 127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95869884 |
| 128 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95841680 |
| 129 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95678352 |
| 130 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.95575646 |
| 131 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94826325 |
| 132 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94269407 |
| 133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93970289 |
| 134 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91558889 |
| 135 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.91151728 |
| 136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89964327 |
| 137 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88929187 |
| 138 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88627116 |
| 139 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88610563 |
| 140 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86688088 |
| 141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86191638 |
| 142 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.85975502 |
| 143 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.85975502 |
| 144 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85554078 |
| 145 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85342204 |
| 146 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84748085 |
| 147 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.83710832 |
| 148 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83680041 |
| 149 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83545699 |
| 150 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.83339802 |
| 151 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.83233684 |
| 152 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83192661 |
| 153 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.82820842 |
| 154 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82169423 |
| 155 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81827263 |
| 156 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.80993259 |
| 157 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.80734202 |
| 158 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80552041 |
| 159 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78812263 |
| 160 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.78702602 |
| 161 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78100722 |
| 162 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.76684127 |
| 163 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.74883286 |
| 164 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74621690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.96760620 |
| 2 | MP0005360_urolithiasis | 4.74981054 |
| 3 | MP0005365_abnormal_bile_salt | 4.44290969 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.22499920 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.94908683 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.87570131 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.75141718 |
| 8 | MP0009785_altered_susceptibility_to | 3.69110171 |
| 9 | MP0003195_calcinosis | 3.38462921 |
| 10 | MP0003763_abnormal_thymus_physiology | 3.17191879 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 3.09760335 |
| 12 | MP0005671_abnormal_response_to | 3.03257174 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.73393184 |
| 14 | MP0009840_abnormal_foam_cell | 2.70305034 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.67989423 |
| 16 | MP0005025_abnormal_response_to | 2.61229508 |
| 17 | MP0003436_decreased_susceptibility_to | 2.60396265 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.59344968 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.54161629 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.51970235 |
| 21 | MP0002419_abnormal_innate_immunity | 2.49400171 |
| 22 | MP0005174_abnormal_tail_pigmentation | 2.43244463 |
| 23 | MP0001873_stomach_inflammation | 2.42563046 |
| 24 | MP0001800_abnormal_humoral_immune | 2.40237153 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.40132294 |
| 26 | MP0000490_abnormal_crypts_of | 2.37836663 |
| 27 | MP0005000_abnormal_immune_tolerance | 2.37153305 |
| 28 | MP0001819_abnormal_immune_cell | 2.36926176 |
| 29 | MP0002006_tumorigenesis | 2.36746118 |
| 30 | MP0003183_abnormal_peptide_metabolism | 2.33275559 |
| 31 | MP0002452_abnormal_antigen_presenting | 2.31172014 |
| 32 | MP0003724_increased_susceptibility_to | 2.28967973 |
| 33 | MP0002723_abnormal_immune_serum | 2.22192084 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 2.20684286 |
| 35 | MP0000685_abnormal_immune_system | 2.16744074 |
| 36 | MP0005332_abnormal_amino_acid | 2.15896491 |
| 37 | MP0003866_abnormal_defecation | 2.09730871 |
| 38 | MP0002398_abnormal_bone_marrow | 2.09687366 |
| 39 | MP0001764_abnormal_homeostasis | 2.06345663 |
| 40 | MP0001790_abnormal_immune_system | 2.05967580 |
| 41 | MP0005387_immune_system_phenotype | 2.05967580 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 2.04354377 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 2.02207663 |
| 44 | MP0003252_abnormal_bile_duct | 2.00552771 |
| 45 | MP0008004_abnormal_stomach_pH | 1.97286083 |
| 46 | MP0002405_respiratory_system_inflammati | 1.94371598 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.93253090 |
| 48 | MP0000716_abnormal_immune_system | 1.92017310 |
| 49 | MP0003718_maternal_effect | 1.90599245 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.90405792 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.88189949 |
| 52 | MP0002009_preneoplasia | 1.85283867 |
| 53 | MP0002722_abnormal_immune_system | 1.71376937 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.67980065 |
| 55 | MP0002429_abnormal_blood_cell | 1.64945579 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.64726425 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.64612553 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.63698051 |
| 59 | MP0002132_abnormal_respiratory_system | 1.62635612 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 1.60147665 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.58622930 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.56646601 |
| 63 | MP0003868_abnormal_feces_composition | 1.56441418 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.55846657 |
| 65 | MP0000609_abnormal_liver_physiology | 1.55729526 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.55539230 |
| 67 | MP0000858_altered_metastatic_potential | 1.54574117 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.49511358 |
| 69 | MP0001663_abnormal_digestive_system | 1.48718160 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.44889233 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.44531639 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.43879666 |
| 73 | MP0002095_abnormal_skin_pigmentation | 1.42054198 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.41196527 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.40922079 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.40922079 |
| 77 | MP0010094_abnormal_chromosome_stability | 1.39632804 |
| 78 | MP0005670_abnormal_white_adipose | 1.35878123 |
| 79 | MP0003075_altered_response_to | 1.34611584 |
| 80 | MP0000343_altered_response_to | 1.32394854 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.32181565 |
| 82 | MP0003300_gastrointestinal_ulcer | 1.31135544 |
| 83 | MP0001853_heart_inflammation | 1.30931932 |
| 84 | MP0005408_hypopigmentation | 1.30679925 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 1.29061078 |
| 86 | MP0004947_skin_inflammation | 1.26865861 |
| 87 | MP0006082_CNS_inflammation | 1.23972790 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 1.21258401 |
| 89 | MP0002277_abnormal_respiratory_mucosa | 1.21146928 |
| 90 | MP0001756_abnormal_urination | 1.20489014 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18241276 |
| 92 | MP0006054_spinal_hemorrhage | 1.17629716 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 1.17104380 |
| 94 | MP0009697_abnormal_copulation | 1.16084792 |
| 95 | MP0008469_abnormal_protein_level | 1.13278328 |
| 96 | MP0001188_hyperpigmentation | 1.12757629 |
| 97 | MP0005330_cardiomyopathy | 1.12109433 |
| 98 | MP0005165_increased_susceptibility_to | 1.11906177 |
| 99 | MP0005409_darkened_coat_color | 1.11714285 |
| 100 | MP0001533_abnormal_skeleton_physiology | 1.08962886 |
| 101 | MP0010368_abnormal_lymphatic_system | 1.08308840 |
| 102 | MP0008057_abnormal_DNA_replication | 1.08276209 |
| 103 | MP0002019_abnormal_tumor_incidence | 1.07661801 |
| 104 | MP0005410_abnormal_fertilization | 1.06003068 |
| 105 | MP0004043_abnormal_pH_regulation | 1.05781837 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 1.05726820 |
| 107 | MP0000477_abnormal_intestine_morphology | 1.02925828 |
| 108 | MP0003303_peritoneal_inflammation | 1.01908181 |
| 109 | MP0001986_abnormal_taste_sensitivity | 1.01619518 |
| 110 | MP0004147_increased_porphyrin_level | 1.00392671 |
| 111 | MP0001661_extended_life_span | 0.99135463 |
| 112 | MP0001666_abnormal_nutrient_absorption | 0.98860339 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.97915390 |
| 114 | MP0000470_abnormal_stomach_morphology | 0.96747511 |
| 115 | MP0005166_decreased_susceptibility_to | 0.96218043 |
| 116 | MP0003111_abnormal_nucleus_morphology | 0.96170456 |
| 117 | MP0004381_abnormal_hair_follicle | 0.95588981 |
| 118 | MP0002933_joint_inflammation | 0.95285817 |
| 119 | MP0005310_abnormal_salivary_gland | 0.94345225 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.94233162 |
| 121 | MP0005451_abnormal_body_composition | 0.93450936 |
| 122 | MP0005376_homeostasis/metabolism_phenot | 0.91841488 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.91724884 |
| 124 | MP0000598_abnormal_liver_morphology | 0.91338473 |
| 125 | MP0003011_delayed_dark_adaptation | 0.91085284 |
| 126 | MP0001664_abnormal_digestion | 0.90986182 |
| 127 | MP0009764_decreased_sensitivity_to | 0.90148172 |
| 128 | MP0003950_abnormal_plasma_membrane | 0.87954846 |
| 129 | MP0010352_gastrointestinal_tract_polyps | 0.86808619 |
| 130 | MP0008058_abnormal_DNA_repair | 0.86713718 |
| 131 | MP0003077_abnormal_cell_cycle | 0.84826676 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.84553527 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.83755879 |
| 134 | MP0005395_other_phenotype | 0.83046169 |
| 135 | MP0008007_abnormal_cellular_replicative | 0.81249501 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.80195310 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.79369476 |
| 138 | MP0005448_abnormal_energy_balance | 0.78466383 |
| 139 | MP0005535_abnormal_body_temperature | 0.77586204 |
| 140 | MP0000516_abnormal_urinary_system | 0.76969404 |
| 141 | MP0005367_renal/urinary_system_phenotyp | 0.76969404 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.73144386 |
| 143 | MP0005266_abnormal_metabolism | 0.73015605 |
| 144 | MP0002971_abnormal_brown_adipose | 0.71613179 |
| 145 | MP0009278_abnormal_bone_marrow | 0.71426200 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.70426675 |
| 147 | MP0003448_altered_tumor_morphology | 0.69429239 |
| 148 | MP0004215_abnormal_myocardial_fiber | 0.68957765 |
| 149 | MP0003186_abnormal_redox_activity | 0.68195041 |
| 150 | MP0001881_abnormal_mammary_gland | 0.67557391 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.67132197 |
| 152 | MP0002693_abnormal_pancreas_physiology | 0.66435898 |
| 153 | MP0009379_abnormal_foot_pigmentation | 0.64437052 |
| 154 | MP0005220_abnormal_exocrine_pancreas | 0.63988459 |
| 155 | MP0005647_abnormal_sex_gland | 0.61901117 |
| 156 | MP0008872_abnormal_physiological_respon | 0.61648915 |
| 157 | MP0010307_abnormal_tumor_latency | 0.61070777 |
| 158 | MP0002877_abnormal_melanocyte_morpholog | 0.60644620 |
| 159 | MP0003786_premature_aging | 0.60393031 |
| 160 | MP0009765_abnormal_xenobiotic_induced | 0.59449288 |
| 161 | MP0001216_abnormal_epidermal_layer | 0.59422138 |
| 162 | MP0004957_abnormal_blastocyst_morpholog | 0.59255827 |
| 163 | MP0003953_abnormal_hormone_level | 0.59238492 |
| 164 | MP0009763_increased_sensitivity_to | 0.59064268 |
| 165 | MP0003191_abnormal_cellular_cholesterol | 0.58164749 |
| 166 | MP0000313_abnormal_cell_death | 0.56867246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.33294366 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.03889955 |
| 3 | Thrombocytosis (HP:0001894) | 4.94154645 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.87588938 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.40408354 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.34449595 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.31799031 |
| 8 | Chronic otitis media (HP:0000389) | 4.30351354 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.21015737 |
| 10 | Complement deficiency (HP:0004431) | 4.17915478 |
| 11 | Myositis (HP:0100614) | 4.16111274 |
| 12 | Deep venous thrombosis (HP:0002625) | 4.08516100 |
| 13 | Abnormality of B cell number (HP:0010975) | 4.00248002 |
| 14 | B lymphocytopenia (HP:0010976) | 4.00248002 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.84890601 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.83889532 |
| 17 | Obstructive lung disease (HP:0006536) | 3.83889532 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.83749526 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.71795120 |
| 20 | Glomerulonephritis (HP:0000099) | 3.61243903 |
| 21 | Pustule (HP:0200039) | 3.60618042 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.57624319 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.57198691 |
| 24 | Periodontitis (HP:0000704) | 3.54662606 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 3.52885542 |
| 26 | Eosinophilia (HP:0001880) | 3.49159511 |
| 27 | Meningitis (HP:0001287) | 3.40410597 |
| 28 | Abnormality of eosinophils (HP:0001879) | 3.33479680 |
| 29 | Hepatic necrosis (HP:0002605) | 3.33254582 |
| 30 | Granulocytopenia (HP:0001913) | 3.30733088 |
| 31 | Recurrent viral infections (HP:0004429) | 3.29821826 |
| 32 | Hypoglycemic seizures (HP:0002173) | 3.24416569 |
| 33 | Acute encephalopathy (HP:0006846) | 3.18089464 |
| 34 | IgM deficiency (HP:0002850) | 3.17629675 |
| 35 | Combined immunodeficiency (HP:0005387) | 3.17628491 |
| 36 | Abnormality of complement system (HP:0005339) | 3.17089864 |
| 37 | Autoimmune hemolytic anemia (HP:0001890) | 3.14114244 |
| 38 | Thyroiditis (HP:0100646) | 3.13889970 |
| 39 | Abnormality of T cells (HP:0002843) | 3.13704083 |
| 40 | T lymphocytopenia (HP:0005403) | 3.10279502 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 3.08794011 |
| 42 | Abnormality of the prostate (HP:0008775) | 3.07571413 |
| 43 | Abnormality of T cell number (HP:0011839) | 3.06265262 |
| 44 | Recurrent skin infections (HP:0001581) | 2.99817762 |
| 45 | Abnormality of urine glucose concentration (HP:0011016) | 2.98540938 |
| 46 | Glycosuria (HP:0003076) | 2.98540938 |
| 47 | Joint hemorrhage (HP:0005261) | 2.97927178 |
| 48 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.97083004 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.96554884 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.94277374 |
| 51 | Poikiloderma (HP:0001029) | 2.94010851 |
| 52 | Hepatocellular necrosis (HP:0001404) | 2.93881645 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.93293929 |
| 54 | Fat malabsorption (HP:0002630) | 2.90951108 |
| 55 | Chronic diarrhea (HP:0002028) | 2.90876400 |
| 56 | Reticulocytopenia (HP:0001896) | 2.90287879 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.88358697 |
| 58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.88285419 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.85649084 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.85649084 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.83814995 |
| 62 | Intrahepatic cholestasis (HP:0001406) | 2.83747920 |
| 63 | Orchitis (HP:0100796) | 2.82577463 |
| 64 | Gingivitis (HP:0000230) | 2.82317585 |
| 65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.82301664 |
| 66 | Optic neuritis (HP:0100653) | 2.81741677 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.81741677 |
| 68 | Recurrent bronchitis (HP:0002837) | 2.81686441 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.81360691 |
| 70 | Nausea (HP:0002018) | 2.79705156 |
| 71 | Increased CSF lactate (HP:0002490) | 2.78737928 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78194056 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78194056 |
| 74 | Cheilitis (HP:0100825) | 2.75965482 |
| 75 | Hyperammonemia (HP:0001987) | 2.74761505 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73706368 |
| 77 | Xanthomatosis (HP:0000991) | 2.71764163 |
| 78 | Cerebral edema (HP:0002181) | 2.68840870 |
| 79 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.67533404 |
| 80 | Recurrent pneumonia (HP:0006532) | 2.65863105 |
| 81 | Symptomatic seizures (HP:0011145) | 2.65582105 |
| 82 | Vasculitis (HP:0002633) | 2.64886902 |
| 83 | Leukocytosis (HP:0001974) | 2.64171766 |
| 84 | Lymphopenia (HP:0001888) | 2.63255067 |
| 85 | Petechiae (HP:0000967) | 2.62839870 |
| 86 | Abnormal number of erythroid precursors (HP:0012131) | 2.60037194 |
| 87 | Hypolipoproteinemia (HP:0010981) | 2.59167771 |
| 88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.58583754 |
| 89 | Progressive macrocephaly (HP:0004481) | 2.57889132 |
| 90 | Prolonged bleeding time (HP:0003010) | 2.54881680 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 2.54312674 |
| 92 | Abnormality of the fingertips (HP:0001211) | 2.52925509 |
| 93 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52601394 |
| 94 | Acanthocytosis (HP:0001927) | 2.50346747 |
| 95 | Abnormality of macrophages (HP:0004311) | 2.48145862 |
| 96 | Sepsis (HP:0100806) | 2.47372182 |
| 97 | Stomatitis (HP:0010280) | 2.47263505 |
| 98 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.47246956 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 2.46868666 |
| 100 | Abnormality of glycolysis (HP:0004366) | 2.46622626 |
| 101 | Cellulitis (HP:0100658) | 2.44580387 |
| 102 | Encephalitis (HP:0002383) | 2.43890800 |
| 103 | Lethargy (HP:0001254) | 2.43439714 |
| 104 | Type I transferrin isoform profile (HP:0003642) | 2.41187543 |
| 105 | Increased hepatocellular lipid droplets (HP:0006565) | 2.40365146 |
| 106 | Vascular calcification (HP:0004934) | 2.39987198 |
| 107 | Lipid accumulation in hepatocytes (HP:0006561) | 2.38862205 |
| 108 | IgG deficiency (HP:0004315) | 2.38849576 |
| 109 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.38355162 |
| 110 | Abnormality of methionine metabolism (HP:0010901) | 2.36956317 |
| 111 | Steatorrhea (HP:0002570) | 2.36863688 |
| 112 | Agammaglobulinemia (HP:0004432) | 2.35976969 |
| 113 | Chromsome breakage (HP:0040012) | 2.35097918 |
| 114 | Renal Fanconi syndrome (HP:0001994) | 2.33313336 |
| 115 | Ketoacidosis (HP:0001993) | 2.30701985 |
| 116 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30287158 |
| 117 | Increased IgE level (HP:0003212) | 2.29846450 |
| 118 | Recurrent sinusitis (HP:0011108) | 2.29739698 |
| 119 | Abnormality of the common coagulation pathway (HP:0010990) | 2.29710599 |
| 120 | Inflammation of the large intestine (HP:0002037) | 2.29372686 |
| 121 | Malnutrition (HP:0004395) | 2.27377773 |
| 122 | Hemoptysis (HP:0002105) | 2.27224319 |
| 123 | Abnormality of vitamin metabolism (HP:0100508) | 2.22756234 |
| 124 | Lymphoma (HP:0002665) | 2.22728519 |
| 125 | Recurrent lower respiratory tract infections (HP:0002783) | 2.22246443 |
| 126 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.21860694 |
| 127 | Osteomyelitis (HP:0002754) | 2.21554869 |
| 128 | Increased muscle lipid content (HP:0009058) | 2.21343817 |
| 129 | Acute myeloid leukemia (HP:0004808) | 2.20967981 |
| 130 | Spontaneous abortion (HP:0005268) | 2.19825607 |
| 131 | Hypoplasia of the thymus (HP:0000778) | 2.19769387 |
| 132 | Metabolic acidosis (HP:0001942) | 2.19757363 |
| 133 | Keratoconjunctivitis sicca (HP:0001097) | 2.19710695 |
| 134 | Urticaria (HP:0001025) | 2.19569740 |
| 135 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19461309 |
| 136 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19461309 |
| 137 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19461309 |
| 138 | Cerebral palsy (HP:0100021) | 2.18834664 |
| 139 | Amyloidosis (HP:0011034) | 2.18483293 |
| 140 | Lactic acidosis (HP:0003128) | 2.18471748 |
| 141 | Skin ulcer (HP:0200042) | 2.18068298 |
| 142 | Abnormality of vitamin B metabolism (HP:0004340) | 2.17360432 |
| 143 | Epistaxis (HP:0000421) | 2.16604601 |
| 144 | Renal cortical cysts (HP:0000803) | 2.15705677 |
| 145 | Hyperphosphaturia (HP:0003109) | 2.14414198 |
| 146 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13397482 |
| 147 | Ketosis (HP:0001946) | 2.12922600 |
| 148 | Respiratory failure (HP:0002878) | 2.12646673 |
| 149 | Purpura (HP:0000979) | 2.12578627 |
| 150 | Hypothermia (HP:0002045) | 2.11828173 |
| 151 | Gastrointestinal inflammation (HP:0004386) | 2.11391294 |
| 152 | Neutropenia (HP:0001875) | 2.11353179 |
| 153 | Chronic sinusitis (HP:0011109) | 2.10080585 |
| 154 | Acute lymphatic leukemia (HP:0006721) | 2.07729232 |
| 155 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.07136914 |
| 156 | Rhabdomyolysis (HP:0003201) | 2.06755362 |
| 157 | Prostate neoplasm (HP:0100787) | 2.05480972 |
| 158 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05246383 |
| 159 | Methylmalonic aciduria (HP:0012120) | 2.05151208 |
| 160 | Pulmonary infiltrates (HP:0002113) | 2.05017165 |
| 161 | Nephritis (HP:0000123) | 2.03903268 |
| 162 | Abnormality of the preputium (HP:0100587) | 2.03470160 |
| 163 | Palpitations (HP:0001962) | 2.02851898 |
| 164 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.01944125 |
| 165 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.01944125 |
| 166 | Clubbing of toes (HP:0100760) | 2.01226957 |
| 167 | Chest pain (HP:0100749) | 2.00350940 |
| 168 | Abnormality of DNA repair (HP:0003254) | 2.00328566 |
| 169 | 3-Methylglutaconic aciduria (HP:0003535) | 2.00201276 |
| 170 | Vacuolated lymphocytes (HP:0001922) | 1.99254337 |
| 171 | Keratoconjunctivitis (HP:0001096) | 1.98706119 |
| 172 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.98534327 |
| 173 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.98534327 |
| 174 | Abnormal protein glycosylation (HP:0012346) | 1.98534327 |
| 175 | Abnormal glycosylation (HP:0012345) | 1.98534327 |
| 176 | Proximal tubulopathy (HP:0000114) | 1.98403699 |
| 177 | Conjugated hyperbilirubinemia (HP:0002908) | 1.98375398 |
| 178 | Hyperglycinemia (HP:0002154) | 1.97704175 |
| 179 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.97340668 |
| 180 | Increased IgM level (HP:0003496) | 1.97228678 |
| 181 | Hydroxyprolinuria (HP:0003080) | 1.95809080 |
| 182 | Abnormality of proline metabolism (HP:0010907) | 1.95809080 |
| 183 | CNS demyelination (HP:0007305) | 1.95705397 |
| 184 | Delayed CNS myelination (HP:0002188) | 1.92059278 |
| 185 | Hemorrhage of the eye (HP:0011885) | 1.91072164 |
| 186 | Increased serum lactate (HP:0002151) | 1.90275405 |
| 187 | Cardiovascular calcification (HP:0011915) | 1.89949090 |
| 188 | Methylmalonic acidemia (HP:0002912) | 1.88252721 |
| 189 | Hyperglycinuria (HP:0003108) | 1.87898442 |
| 190 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.85755637 |
| 191 | Abnormality of glycine metabolism (HP:0010895) | 1.85755637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.03862728 |
| 2 | MAP4K1 | 3.81108564 |
| 3 | IRAK4 | 3.60010402 |
| 4 | INSRR | 3.50103756 |
| 5 | PDK2 | 3.47110601 |
| 6 | VRK2 | 2.92334906 |
| 7 | KIT | 2.91671539 |
| 8 | TEC | 2.44894678 |
| 9 | FLT3 | 2.37472664 |
| 10 | BLK | 2.34908518 |
| 11 | ZAP70 | 2.25264013 |
| 12 | EIF2AK3 | 2.24889923 |
| 13 | IKBKE | 2.21674988 |
| 14 | EIF2AK1 | 2.14530403 |
| 15 | MST4 | 2.11866508 |
| 16 | BCKDK | 2.10081530 |
| 17 | STK16 | 1.98518210 |
| 18 | ARAF | 1.97200218 |
| 19 | MAP4K2 | 1.96208830 |
| 20 | TYK2 | 1.96000411 |
| 21 | MAP3K14 | 1.94453483 |
| 22 | BTK | 1.94074997 |
| 23 | JAK3 | 1.80368191 |
| 24 | ADRBK2 | 1.80246352 |
| 25 | TESK2 | 1.78243877 |
| 26 | IRAK3 | 1.78047308 |
| 27 | NME2 | 1.70692470 |
| 28 | GRK6 | 1.69387803 |
| 29 | CLK1 | 1.65990022 |
| 30 | VRK1 | 1.59911342 |
| 31 | PBK | 1.55726845 |
| 32 | TIE1 | 1.53523995 |
| 33 | TAOK3 | 1.49962129 |
| 34 | ITK | 1.48416281 |
| 35 | EEF2K | 1.46563650 |
| 36 | FER | 1.45663945 |
| 37 | STK10 | 1.42640206 |
| 38 | MAP3K12 | 1.41914263 |
| 39 | CSF1R | 1.41135025 |
| 40 | SYK | 1.36254205 |
| 41 | RIPK4 | 1.35022125 |
| 42 | MAP2K3 | 1.34237998 |
| 43 | TNK2 | 1.32098741 |
| 44 | FRK | 1.31430419 |
| 45 | LCK | 1.28588228 |
| 46 | ABL2 | 1.27337617 |
| 47 | OBSCN | 1.24379240 |
| 48 | TBK1 | 1.24239436 |
| 49 | KDR | 1.23222903 |
| 50 | PIM2 | 1.23041040 |
| 51 | TGFBR2 | 1.22634785 |
| 52 | YES1 | 1.21286791 |
| 53 | EPHA2 | 1.17391315 |
| 54 | MAP2K6 | 1.16929322 |
| 55 | STK39 | 1.16520881 |
| 56 | NUAK1 | 1.13951345 |
| 57 | TESK1 | 1.10333017 |
| 58 | NEK1 | 1.10075599 |
| 59 | JAK1 | 1.09786150 |
| 60 | LYN | 1.09193160 |
| 61 | TRPM7 | 1.08046485 |
| 62 | HCK | 1.07881925 |
| 63 | NME1 | 1.06108678 |
| 64 | IKBKB | 1.03094462 |
| 65 | PRKAA2 | 1.02193785 |
| 66 | BRD4 | 1.01666222 |
| 67 | OXSR1 | 1.00970621 |
| 68 | MATK | 1.00634013 |
| 69 | PIM1 | 0.97795739 |
| 70 | PASK | 0.96225322 |
| 71 | MAP3K3 | 0.93917703 |
| 72 | SCYL2 | 0.93148605 |
| 73 | ZAK | 0.92418612 |
| 74 | NLK | 0.92333956 |
| 75 | FES | 0.92264305 |
| 76 | CSK | 0.91895262 |
| 77 | SIK3 | 0.91403652 |
| 78 | PRKG2 | 0.89809225 |
| 79 | WNK4 | 0.87698726 |
| 80 | GRK1 | 0.86014872 |
| 81 | ILK | 0.85515970 |
| 82 | MYLK | 0.82281142 |
| 83 | DAPK1 | 0.82001218 |
| 84 | FGFR3 | 0.81909014 |
| 85 | MKNK1 | 0.81379854 |
| 86 | SRPK1 | 0.79979610 |
| 87 | PIK3CA | 0.79121702 |
| 88 | MKNK2 | 0.78845500 |
| 89 | ERN1 | 0.78334403 |
| 90 | STK4 | 0.76996940 |
| 91 | EIF2AK2 | 0.76587541 |
| 92 | MAPKAPK3 | 0.75081564 |
| 93 | CHUK | 0.74623643 |
| 94 | LRRK2 | 0.73904641 |
| 95 | PHKG2 | 0.72541082 |
| 96 | PHKG1 | 0.72541082 |
| 97 | MST1R | 0.72499327 |
| 98 | RPS6KL1 | 0.71824490 |
| 99 | RPS6KC1 | 0.71824490 |
| 100 | RPS6KA6 | 0.69940889 |
| 101 | MAP3K6 | 0.69359043 |
| 102 | MAP3K2 | 0.68519142 |
| 103 | RPS6KA4 | 0.65762721 |
| 104 | PDPK1 | 0.63708491 |
| 105 | RPS6KB2 | 0.62615708 |
| 106 | TNIK | 0.62525679 |
| 107 | PKN2 | 0.62453982 |
| 108 | MAPKAPK5 | 0.60783990 |
| 109 | FGFR4 | 0.60721530 |
| 110 | ATR | 0.60483514 |
| 111 | ERBB4 | 0.59187734 |
| 112 | PIK3CG | 0.59142002 |
| 113 | HIPK2 | 0.58772034 |
| 114 | CDK7 | 0.57849256 |
| 115 | CSNK2A2 | 0.57154710 |
| 116 | MAPK4 | 0.56737209 |
| 117 | STK24 | 0.56207527 |
| 118 | BMPR1B | 0.54611017 |
| 119 | RPS6KB1 | 0.53095128 |
| 120 | MAP3K11 | 0.52886816 |
| 121 | MAPK11 | 0.52883385 |
| 122 | PRKCD | 0.52824850 |
| 123 | RPS6KA2 | 0.52295807 |
| 124 | MAP3K13 | 0.52202946 |
| 125 | PRPF4B | 0.49784048 |
| 126 | MAP3K8 | 0.49775469 |
| 127 | CDK6 | 0.49720768 |
| 128 | MAP3K10 | 0.49120334 |
| 129 | ACVR1B | 0.47042688 |
| 130 | CSNK2A1 | 0.46591532 |
| 131 | CDK8 | 0.45954601 |
| 132 | MAPKAPK2 | 0.45208600 |
| 133 | ERBB3 | 0.44556577 |
| 134 | CDC7 | 0.44158214 |
| 135 | GRK7 | 0.43825200 |
| 136 | DAPK3 | 0.42767532 |
| 137 | IGF1R | 0.41755664 |
| 138 | PDK1 | 0.41753530 |
| 139 | PRKCI | 0.41575910 |
| 140 | PRKACG | 0.40263913 |
| 141 | PRKCQ | 0.38616571 |
| 142 | EPHB1 | 0.38597096 |
| 143 | LMTK2 | 0.38480101 |
| 144 | BRSK2 | 0.38457710 |
| 145 | TGFBR1 | 0.37806740 |
| 146 | CDK9 | 0.37458253 |
| 147 | TLK1 | 0.37349591 |
| 148 | BMPR2 | 0.37045998 |
| 149 | MAP3K1 | 0.36218704 |
| 150 | AKT3 | 0.36215334 |
| 151 | PAK4 | 0.35745598 |
| 152 | TAOK2 | 0.32705448 |
| 153 | PRKCA | 0.31475001 |
| 154 | CSNK1G3 | 0.31215389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.57930030 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.40229740 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50044225 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48695434 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43897677 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.32037589 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.30016066 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25683879 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.25522259 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18880115 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.18341757 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.13186826 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.12748602 |
| 14 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08860783 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07598177 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.06281898 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05056013 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02070065 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.01660166 |
| 20 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99893363 |
| 21 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96548606 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.95658621 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.91352872 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82892675 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.82439371 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.82061831 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81795619 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80349914 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80048150 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.79051841 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74981543 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.73823197 |
| 33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.70941286 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.70657324 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.69406505 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69193327 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68808356 |
| 38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.66043816 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.65963691 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63807897 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 1.63044102 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60999823 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.60653090 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.59612552 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.56237293 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55704877 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54625577 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53412379 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52683320 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52232213 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48465169 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47844665 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46228061 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46032411 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.44833440 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40775567 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39908072 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39506162 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35735021 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29993021 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29762578 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 1.27970995 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26965321 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26671310 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25383320 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23657169 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 1.23239810 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.22501945 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.15084507 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12944866 |
| 71 | Protein export_Homo sapiens_hsa03060 | 1.11731118 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10862054 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 1.10696793 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.08738605 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08708885 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05994898 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 1.05221272 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04289314 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03448464 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03274361 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02986683 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02734192 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 1.01024242 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00202704 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99682683 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98831112 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97406643 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.94158479 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93895788 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.92436764 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92414077 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.92193358 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.89761231 |
| 94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87979457 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87661476 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.86761781 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86188118 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84839735 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.83808755 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83574865 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82721581 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82209974 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81515089 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81514182 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80525277 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79739625 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.78401603 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78373822 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77749173 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.77472384 |
| 111 | Cell cycle_Homo sapiens_hsa04110 | 0.76591171 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.76440105 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76309622 |
| 114 | Spliceosome_Homo sapiens_hsa03040 | 0.76272633 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.75549870 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75219222 |
| 117 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75165408 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74250155 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73356655 |
| 120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72734043 |
| 121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72453919 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70716729 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69814595 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.68363833 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68320127 |
| 126 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68214753 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68149219 |
| 128 | Asthma_Homo sapiens_hsa05310 | 0.67357867 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66446771 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.66087754 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65732667 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.64923557 |
| 133 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61520034 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.61263454 |
| 135 | Platelet activation_Homo sapiens_hsa04611 | 0.60889446 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60590388 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.60433825 |
| 138 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59844855 |
| 139 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57803294 |
| 140 | Purine metabolism_Homo sapiens_hsa00230 | 0.55992952 |
| 141 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55481136 |
| 142 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52855331 |
| 143 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52732752 |
| 144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52245206 |
| 145 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52052849 |
| 146 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52030991 |
| 147 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.51652619 |
| 148 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50153113 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50050066 |
| 150 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49806464 |
| 151 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49744519 |
| 152 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49733119 |
| 153 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47333982 |
| 154 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46950099 |
| 155 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45810150 |
| 156 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.44977525 |
| 157 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43049642 |
| 158 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42369050 |
| 159 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42151361 |
| 160 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41611372 |
| 161 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41243995 |
| 162 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40649759 |
| 163 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39297153 |
| 164 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39104866 |
| 165 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35387726 |
| 166 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34004684 |

